Fisher Asset Management LLC Lowers Stock Position in The Clorox Company (NYSE:CLX)

Fisher Asset Management LLC lowered its stake in The Clorox Company (NYSE:CLX - Free Report) by 10.4% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 26,051 shares of the company's stock after selling 3,017 shares during the period. Fisher Asset Management LLC's holdings in Clorox were worth $4,244,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Catalyst Capital Advisors LLC acquired a new position in Clorox in the 3rd quarter valued at $54,000. Raymond James & Associates raised its holdings in Clorox by 32.8% during the second quarter. Raymond James & Associates now owns 267,632 shares of the company's stock worth $36,524,000 after purchasing an additional 66,149 shares in the last quarter. M&G Plc acquired a new stake in Clorox in the second quarter valued at about $876,000. Cetera Investment Advisers lifted its position in Clorox by 140.6% in the first quarter. Cetera Investment Advisers now owns 74,032 shares of the company's stock valued at $11,335,000 after purchasing an additional 43,265 shares during the period. Finally, AQR Capital Management LLC boosted its holdings in Clorox by 8.6% in the 2nd quarter. AQR Capital Management LLC now owns 287,277 shares of the company's stock valued at $39,121,000 after purchasing an additional 22,676 shares in the last quarter. Hedge funds and other institutional investors own 78.53% of the company's stock.

Clorox Price Performance

CLX stock traded down $0.01 on Friday, reaching $167.14. The company had a trading volume of 465,385 shares, compared to its average volume of 1,238,729. The company's fifty day moving average is $163.09 and its 200 day moving average is $149.32. The company has a market cap of $20.69 billion, a P/E ratio of 58.24, a PEG ratio of 3.09 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.35.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the company earned $0.49 earnings per share. The business's revenue for the quarter was up 27.0% compared to the same quarter last year. On average, research analysts forecast that The Clorox Company will post 6.85 earnings per share for the current year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.92%. The ex-dividend date is Wednesday, January 29th. Clorox's dividend payout ratio is presently 170.04%.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares of the company's stock, valued at approximately $2,229,719.92. This trade represents a 11.40 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.57% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts have recently commented on the company. DA Davidson raised their price target on Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a report on Monday, November 4th. JPMorgan Chase & Co. raised their target price on Clorox from $148.00 to $174.00 and gave the company a "neutral" rating in a report on Friday, October 11th. BNP Paribas upgraded shares of Clorox to a "strong sell" rating in a research report on Friday, September 6th. TD Cowen upgraded shares of Clorox from a "sell" rating to a "hold" rating and increased their price target for the company from $155.00 to $170.00 in a report on Wednesday, November 6th. Finally, Citigroup raised their price objective on shares of Clorox from $165.00 to $170.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. Five research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.